{
    "title": "Drugmaker Hikma trims sales forecasts, shares fall",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4798480/Drugmaker-Hikma-sees-2017-guidance-lower-end-shares-slide.html",
    "date": "2017-08-17",
    "keywords": [
        "company",
        "revenue",
        "guidance",
        "business",
        "thursday",
        "industry",
        "percent",
        "price",
        "erosion",
        "hoffmann",
        "justin",
        "george",
        "end",
        "drug",
        "forecast",
        "range",
        "year",
        "level",
        "hikma",
        "decision",
        "version",
        "advair",
        "pricing",
        "firm",
        "generic",
        "currency",
        "low",
        "pence",
        "president",
        "companys",
        "rest",
        "hoffman",
        "profitability",
        "thirdparty",
        "workforce",
        "headcount",
        "downgrade",
        "commentary",
        "quarter",
        "stanley",
        "drugmaker",
        "drop",
        "month",
        "glaxosmithkline",
        "plcs",
        "blockbuster",
        "lung",
        "application",
        "time",
        "total",
        "estimate",
        "fda",
        "progress",
        "number",
        "timeline",
        "product",
        "approval",
        "rise",
        "june",
        "core",
        "operating",
        "profit",
        "line",
        "statement",
        "deal",
        "manufacture",
        "care",
        "east",
        "north",
        "reporting",
        "bengaluru",
        "editing",
        "edmund",
        "blair",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}